- Home
- HMR vs ASRT Comparison
HMR vs ASRT Comparison
Compare HMR & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMR | ASRT |
|---|---|---|
| Founded | 1984 | 1995 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.1M | 69.2M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | HMR | ASRT |
|---|---|---|
| Price | $1.09 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $3.00 |
| AVG Volume (30 Days) | 43.1K | ★ 755.4K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $36,086,264.00 | ★ $137,354,000.00 |
| Revenue This Year | $52.26 | N/A |
| Revenue Next Year | $45.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.41 | ★ 9.22 |
| 52 Week Low | $1.07 | $0.51 |
| 52 Week High | $10.04 | $1.04 |
Technical Indicators
Market Signals| Indicator | HMR | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 34.67 | 49.01 |
| Support Level | $1.11 | $0.65 |
| Resistance Level | $1.14 | $0.79 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 14.29 | 84.21 |
Price Performance
Historical ComparisonAbout HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.